HONG JING BIOTECH INC.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Molecular Diagnostic Services in the Field of Oncology and Hematology
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2013
Unified Business No.
54035934
Status
Active
Number of Employees
28
Total Paid-in
Capital
12,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Femtopath is a global brand under Taiwan's HONG JING BIOTECH INC., primarily focusing on molecular diagnostics in the fields of oncology and hematology. We are committed to designing and producing mutation-specific oligonucleotide primers, providing users with high-sensitivity mutation enrichment technology. One of the key features of our technology is reversing the mutant/wild-type ratio through PCR. In Sanger sequencing, our customers are able to determine the mutation types in various sample types (such as FFPE, body fluids, blood, FNA, and cell blocks).
(The content above was translated by AI.)
(The content above was translated by AI.)
